Counterfeiting is gravely impacting the pharmaceuticals industry by causing substantial losses in terms of revenue and credibility. Counterfeit pharmaceutical products, labelled with the names of original and legitimate product manufacturers are entering local markets globally. This has become a matter of serious concern for pharmaceutical companies, and the threat of lawsuits is a constant worry. Players in the pharmaceutical industry around the globe are increasingly working on ways to stop counterfeit products from penetrating the markets in order to prevent negative impact on their sales revenue and brand image.
Counterfeit pharmaceutical products are so very well packed that normal identification techniques are unable to differentiate between legitimate or original packaging and counterfeit ones. These products then end up being sent to the retail market for sale. Forged products, due to sub-standard quality, pose severe health concerns among consumers, which results in steadily diminishing brand image of original products. Each year, multi-million dollar losses are incurred by players in the global pharmaceutical industry due to presence of counterfeit products in their supply chain.
Pharmaceutical products are one of the basic needs of consumer and this high need for medication invariably results in them coming in contact with counterfeit products due to the abundant availability of such products in local markets. Anti-counterfeit pharmaceuticals packaging has emerged as one of the most effective solutions to limit counterfeiting in the pharmaceutical industry. Growing incidence of counterfeiting in the pharmaceutical industry is resulting in increasing demand for anti-counterfeit pharmaceuticals packaging. This market is expected to expand at a significantly high growth rate over the forecast period as a result.
Innovation in anti-counterfeit packaging technology and growing awareness among end-users are factors attributing majorly to growth of the anti-counterfeit pharmaceuticals packaging market. Government regulations in various countries across the globe is prompting players in the global market to invest more in advanced anti-counterfeit technologies. Due to these factors, the anti-counterfeit pharmaceuticals packaging market is expected to account for substantially high revenue growth over the forecast period.
High capital expenditure of anti-counterfeit technology systems and their impact on the product distribution system and supply chain network of companies is making investors a little hesitant to set up manufacturing plants. These are some of the factors that are expected to act as restraint to the growth of the anti-counterfeit pharmaceuticals packaging market over the forecast period.
The global anti-counterfeit pharmaceuticals packaging market is segmented on the basis of technology and regions. The technology segment is categorized into authentication packaging technology and track and trace packaging technology. The authentication technology is further sub-segmented into ink & dyes, holograms, watermarks and taggants. The track and trace packaging technology segment is sub-segmented into barcode technology and RFID technology.
Geographically, the global anti-counterfeit pharmaceuticals packaging market is segmented into seven main regions namely North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Middle East & Africa, and Japan. Due to higher consumer awareness, North America is expected to hold largest market share in the global anti-counterfeit pharmaceuticals packaging market, followed by Europe. The market in Asia Pacific is also expected to grow at a significant rate, adding more value to the global anti-counterfeit pharmaceuticals packaging market over the forecast period.
Some key players in the global market include Zebra Technologies, Alien Technology Corp., AlpVision, Avery Dennison Corp., SICPA HOLDING SA, Microtrace, LLC, Impinj, Inc. and others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.